Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Plos Pathogens|February 6, 2025
Activating PKC-ε induces HIV expression with improved tolerabilityAlivelu M Irrinki, Jasmine Kaur, Bally Randhawa, et al.Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.Plos Pathogens|April 16, 2016
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-LymphocytesR Brad Jones, Stefanie Mueller, Rachel O'Connor, et al.Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.Scientific Reports|February 23, 2023
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSheli R Radoshitzky, Patrick Iversen, Xianghan Lu, et al.Journal of Medicinal Chemistry|October 1, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure ProphylaxisEda Canales, Winston Tse, Scott D Schroeder, et al.Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.European Journal of Epidemiology|November 22, 2020
Cohort profile: Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO)Evelyn Xiu Ling Loo, Shu-E Soh, See Ling Loy, et al.Pageof 7